A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer vaccine research are converging into a new era of more precise, personalized, ...
Knowable Magazine reports on advancements in pancreatic cancer treatment, including new drugs, vaccines, and early diagnostic ...
The FDA's breakthrough therapy designation facilitates accelerated development and regulatory review for therapies showing ...
Inovio Pharmaceuticals faces an October 30 PDUFA date for INO-3107 with high regulatory risk and only a 5-7 month cash runway. Read why INO stock is a hold.
A new comprehensive review from researchers at the Icahn School of Medicine at Mount Sinai details how decades of cancer vaccine research are converging into a new era of more precise, personalized, ...
Drinks like green tea, coffee, berry smoothies, and others contain nutrients that can help support memory, focus, and overall brain health.
T cells are central mediators of autoimmune disease pathogenesis, yet their functional states are not defined solely by antigen recognition or canonical ...
Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...
A year-and-a-half after the In-Custody Death Review Division was created within a state agency, the office has yet to obtain ...
Consumer Reports states that Verizon, Lively, AT&T, Optimum, and USCellular are phone carriers that customers should probably avoid.
The patient with significant bone marrow involvement had complete bone morphological remission. In this patient in which 95% ...
Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets TRBC2-positive T-cell cancers, expanding a precision approach they established ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results